Table 2 Attrition (/1000patient-months of follow-up) by enrolment characteristics
Enrolment characteristic | Numb dead or LTFu | Total months in care | Attrition (/1000 patient−mths of follow-up) (95% CI) |
|---|---|---|---|
Overall | 685 | 88,126 | 7.8 (7.2–8.4) |
Gender | |||
Female | 363 | 58,886 | 6.2 (5.5–6.8) |
Male | 322 | 29,240 | 11.0 (9.8–12.2) |
Age group | |||
15–19 | 12 | 918 | 13.1 (5.7–20.4) |
20–24 | 86 | 5191 | 16.6 (13.1–20.0) |
25–34 | 295 | 36,680 | 8.0 (7.1–9.0) |
35–44 | 209 | 29,531 | 7.1 (6.1–8.0) |
45–54 | 68 | 12,454 | 5.5 (4.2–6.8) |
55Plus | 15 | 3352 | 4.5 (2.2–6.7) |
Marital status | |||
Single | 230 | 18,942 | 12.1 (10.6–13.7) |
Married | 335 | 52,154 | 6.4 (5.7–7.1) |
Divorced | 43 | 5393 | 8.0 (5.6–10.3) |
Widowed | 39 | 7934 | 4.9 (3.4–6.5) |
Not documented | 38 | 3703 | 10.3 (7.0–13.5) |
Residency | |||
Rural | 65 | 14,908 | 4.4 (3.3–5.4) |
Urban | 553 | 66,661 | 8.3 (7.6–9.0) |
Not documented | 67 | 6557 | 10.2 (7.8–12.7) |
Point of entry into care | |||
VCT | 327 | 38,075 | 8.6 (7.7–9.5) |
PMTCT | 66 | 17,440 | 3.8 (2.9–4.7) |
TB Clinic | 37 | 9731 | 3.8 (2.6–5.0) |
Inpatient | 46 | 6150 | 7.5 (5.3–9.6) |
Outpatient | 12 | 1061 | 11.3 (4.9–17.7) |
Other facility | 11 | 1049 | 10.5 (4.3–16.7) |
Other source | 63 | 4280 | 14.7 (11.1–18.3) |
Not documented | 123 | 10,340 | 11.9 (9.8–14.0) |
YoEnr vs YoDg | |||
YoEnr ≠YoDg | 59 | 10,027 | 5.9 (4.4–7.4) |
YoEnr = YoDg | 257 | 45,336 | 5.7 (5.0–6.4) |
YoDg not documented | 369 | 32,763 | 11.3 (10.1–12.4) |
Disease stage (WHO) | Â | Â | |
Stage 1–2 | 354 | 62,334 | 5.7 (5.1–6.3) |
Stage 3–4 | 119 | 24,099 | 4.9 (4.1–5.8) |
Not documented | 212 | 1693 | 125.2 (109.5–141.0) |
CD4 count | |||
0–100 | 37 | 6218 | 6.0 (4.0–7.9) |
101–200 | 28 | 5561 | 5.0 (3.2–6.9) |
201–250 | 8 | 2917 | 2.7 (0.8–4.6) |
251–350 | 31 | 9506 | 3.3 (2.1–4.4) |
351–500 | 85 | 19,328 | 4.4 (3.5–5.3) |
> 500 | 216 | 34,222 | 6.3 (5.5–7.2) |
Not documented | 280 | 10,374 | 27.0 (23.9–30.1) |
TB | |||
No | 654 | 80,707 | 8.1 (7.5–8.7) |
Yes | 31 | 7419 | 4.2 (2.7–5.6) |
PCP | |||
No | 662 | 83,205 | 8.0 (7.4–8.6) |
Yes | 23 | 4921 | 4.7 (2.8–6.6) |
Oral candidiasis | |||
No | 673 | 84,681 | 7.9 (7.3–8.5) |
Yes | 12 | 3445 | 3.5 (1.5–5.5) |
Other OI | |||
No | 504 | 51,738 | 9.7 (8.9–10.6) |
Yes | 181 | 36,388 | 5.0 (4.3–5.7) |
Any OI | |||
No | 472 | 44,453 | 10.6 (9.7–11.6) |
Yes | 213 | 43,673 | 4.9 (4.2–5.5) |
Cryptococcal disease | |||
No | 683 | 87,641 | 7.8 (7.2–8.4) |
Yes | 2 | 485 | 4.1 (0–9.8) |
Oesophageal candidiasis | |||
No | 679 | 87,725 | 7.7 (7.2–8.3) |
Yes | 6 | 401 | 15.0 (3.1–26.8) |
Kaposi’s sarcoma | |||
No | 681 | 87,567 | 7.8 (7.2–8.4) |
Yes | 4 | 559 | 7.2 (0.2–14.1) |
Lymphoma | |||
No | 684 | 88,084 | 7.8 (7.2–8.3) |
Yes | 1 | 42 | 23.8 (0–69.9) |